- Lipitor may be the first statin to switch to OTC
- FDA approves Takeda's Brintellix for depression
- Takeda and Lundbeck announce Brintellix for treatment of MDD
- Federal government must find alternatives to rescheduling hydrocodone combination drugs
- FDA approves liquid form of Merck HIV drug Isentress for infants, small children
BALTIMORE — The Food and Drug Administration has approved a generic psychiatric drug made by Lupin Pharmaceuticals, Lupin said Thursday.
The Indian drug maker announced the approval of escitalopram tablets in the 5-mg, 10-mg and 20-mg strengths, used for acute and maintenance treatment of major depressive disorder in adults and adolescents and for acute treatment of general anxiety disorder in adults.
The drug is a generic version of Forest Labs' Lexapro, which had sales of about $2.7 billion during the 12-month period that ended in June 2012, according to IMS Health.